How different buprenorphine prescribing methods affect patient care for opioid use disorder
Impact of initial buprenorphine prescribing strategies on retention in care for patients with opioid use disorder
This study looks at how different ways of prescribing buprenorphine, a medication for treating opioid use disorder, can help keep patients in treatment longer, so we can find the best methods to support people on their recovery journey.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Boston Medical Center NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11090363 on NIH RePORTER |
What this research studies
This research investigates how various prescribing strategies for buprenorphine, a medication used to treat opioid use disorder (OUD), influence patient retention in care. It aims to analyze current dosage practices and their effectiveness in keeping patients engaged in treatment over time. By examining different dosage regimens, the study seeks to identify which methods lead to better long-term outcomes for individuals struggling with OUD. The findings could help healthcare providers optimize treatment plans to improve patient adherence and success.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with opioid use disorder who are starting or currently receiving buprenorphine treatment.
Not a fit: Patients who are not diagnosed with opioid use disorder or those who are not receiving buprenorphine treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved retention rates in treatment for patients with opioid use disorder, ultimately reducing the risk of overdose and enhancing recovery outcomes.
How similar studies have performed: Previous research has shown that optimizing medication dosage can improve treatment retention in similar patient populations, suggesting that this approach may yield beneficial results.
Where this research is happening
Boston, United States
- Boston Medical Center — Boston, United States (Active)
Researchers
- Principal investigator: Tilhou, Alyssa — Boston Medical Center
- Study coordinator: Tilhou, Alyssa
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.